Autism and neurodevelopmental regenerative research

Regulatory context comes first

Regenerative medicine therapies have not been approved by the FDA to treat autism in the United States. The FDA also states that there are no FDA-approved exosome products.

This is a high-sensitivity paediatric and neurodevelopmental area. Commercial availability, a clinic listing or the use of research language does not establish that an intervention is safe, effective or appropriate for a child or adult.

What registered research in this area looks like

Academic work in this area does exist and is publicly registered. ClinicalTrials.gov record NCT04089579, for example, is a completed phase II study run by Duke University examining umbilical cord tissue-derived mesenchymal stromal cells in children with autism spectrum disorder.

That record is included here as research context and nothing more. It is not connected to any clinic listed on this site, it does not establish that the intervention works, and a completed trial is not the same as an approved treatment. Registry records are public — you can read the sponsor, phase, status and outcome measures yourself.

Distinguish research from routine treatment

A registered study and a routinely sold treatment are not the same thing. Before considering participation in research, verify the study independently and ask who is responsible for oversight, participant safety and follow-up.

• Is this a registered clinical trial, and what is its current recruitment status?
• Who are the named investigators and sponsoring institution?
• Which independent ethics or institutional review board reviewed the protocol?
• What age and eligibility criteria apply, and how are consent and age-appropriate assent handled?
• What endpoints are measured, over what period, and are they defined before enrollment?
• How are adverse events monitored, reported and treated?
• What follow-up is provided after participation ends?
• Am I being asked to pay to take part, and if so, why?

Reading citations on a clinic page

Clinic pages in this area often list published studies. Check whether each cited study used the same product this clinic supplies, whether it involved this clinic at all, and whether it reports clinical outcomes rather than laboratory or animal findings. Genuine citations can still be unrelated to the treatment being sold.

What this guide does not do

Stem Cell Navigator does not rank autism interventions, compare them as substitutes, or recommend stem cells, exosomes, peptides or any regenerative product for autism. This page provides educational and regulatory context only, and autism is deliberately kept out of routine provider filtering on this site.